Cell Source, Inc. Stock Other OTC
Equities
CLCS
US15114L1044
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 29.96M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -5M | EV / Sales 2021 | - |
Net Debt 2021 | 6.4M | Net Debt 2022 | 7.68M | EV / Sales 2022 | - |
P/E ratio 2021 |
-6.58
x | P/E ratio 2022 |
-4.68
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 70.08% |
Managers | Title | Age | Since |
---|---|---|---|
Itamar Shimrat
CEO | Chief Executive Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Brown
CHM | Chairman | 74 | 14-06-29 |
Itamar Shimrat
CEO | Chief Executive Officer | 63 | - |
Darlene Soave
BRD | Director/Board Member | 80 | 21-03-24 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |